Recombinant ODC1 antibody (full length)

Catalog No. ABIN7878765

The Mouse Monoclonal anti-ODC1 antibody is suitable to detect ODC1 in samples from Human. It has been validated for WB and ELISA.

Quick Overview for Recombinant ODC1 antibody (full length) (ABIN7878765)

Target: ODC1 (Ornithine Decarboxylase 1 (ODC1))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This ODC1 antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Clone: RODC1-487

Product Details anti-ODC1 Antibody

Binding Specificity: full length

Purpose: Recombinant Ornithine Decarboxylase Antibody / ODC1

Purification: Protein A/G affinity

Immunogen: Recombinant full-length human protein was used as the immunogen for the recombinant Ornithine Decarboxylase antibody.

Isotype: IgG1, kappa

Application Details

Application Notes: Optimal dilution of the recombinant Ornithine Decarboxylase antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Aliquot the recombinant Ornithine Decarboxylase antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for ODC1

Target: ODC1 (Ornithine Decarboxylase 1 (ODC1))

Alternative Name: Ornithine Decarboxylase

Background: Recognizes a 51-53 kDa protein, identified as the Ornithine Decarboxylase (ODC-1). ODC is the initial and rate-limiting enzyme in the biosynthetic pathway of polyamines and is involved in the conversion of ornithine to putrescine. The biological activity of ODC-1 is rapidly induced in response to virtually all agents known to promote cell proliferation including hormones, drugs, growth factors, mitogens, and tumor promoters. Reportedly, ODC mRNA levels are elevated in lung carcinomas as well as in colon adenomas and carcinomas. ODC activity in colorectal carcinomas is greater than those in adenomas and normal mucosa.

UniProt: P11926